Skip to main content
. 2004 Jul;58(1):26–33. doi: 10.1111/j.1365-2125.2004.02108.x

Table 2. Absolute mean values for baselines by sequence with 95% CI for mean.

Baseline (first) 95% CI Baseline (second) 95% CI
NO (p.p.b) 10.5 5.3, 15.6 9.0 3.9, 14.2
FEV1 (l) 2.58 2.19, 2.97 2.59 2.20, 2.99
FEV1 (% predicted) 84 77, 92 84 77, 92
FEF25–75 (l s−1) 2.14 1.75, 2.54 2.18 1.78, 2.57
FEF25–75 (% predicted) 58 49, 67 59 50, 68
Methacholine PC20 (mg ml−1) 0.7 0.4, 1.2 0.6 0.4, 1.1
PEF (am) (l min−1) 474 429, 518 466 421, 510
PEF (pm) (l min−1) 475 433, 518 470 428, 513
Asthma symptom score (am) 0.1 −0.1, 0.3 0.2 0.1, 0.3
Asthma symptom score (pm) 0.3 0.1, 0.5 0.3 0.1, 0.5
Rescue (am) (puffs/day) 0.1 −0.1, 0.3 0.2 0.1, 0.5
Rescue (pm) (puffs/day) 0.4 0.1, 0.7 0.4 0.1, 0.7
Activities (MiniAQLQ) 6.51 6.27, 6.75 6.63 6.39, 6.87
Symptoms (MiniAQLQ) 5.93 5.50, 6.35 5.91 5.48, 6.33
Emotions (MiniAQLQ) 6.30 5.83, 6.77 6.25 5.78, 6.71
Environment (MiniAQLQ) 5.84 5.35, 6.33 6.05 5.56, 6.54
Overall (MiniAQLQ) 6.14 5.81, 6.47 6.20 5.87, 6.52

There were no significant differences for comparisons between baselines in sequence irrespective of randomized treatments. Data for methacholine PC20are given in geometric means.